TY - JOUR
T1 - A prospective evaluation of postoperative swallowing function and dysphagia following endoscopic laryngopharyngeal surgery
AU - Mizuno, Keisuke
AU - Kishimoto, Yo
AU - Kawai, Yoshitaka
AU - Fujimura, Shintaro
AU - Iwanaga, Ken
AU - Mizuno, Kayoko
AU - Shimizu, Takahiro
AU - Yokoyama, Akira
AU - Nikaido, Mitsuhiro
AU - Hirohashi, Kenshiro
AU - Muto, Manabu
AU - Seno, Hiroshi
AU - Tateya, Ichiro
AU - Omori, Koichi
N1 - Publisher Copyright:
© 2023, The Author(s) under exclusive licence to Japan Society of Clinical Oncology.
PY - 2023/4
Y1 - 2023/4
N2 - Background: Endoscopic laryngopharyngeal surgery (ELPS) is a minimally invasive transoral surgery for superficial pharyngeal and laryngeal cancer, but dysphagia occasionally occurs post-treatment. We investigated dysphagia following ELPS and its risk factors. Methods: Of the 145 patients who underwent ELPS, 92 were evaluated in this study using the Hyodo score, Functional Outcome Swallowing Scale, Eating Assessment Tool-10 along with the total scores for the three items of the method of intake, time, and food preoperatively and on postoperative 1, 3, and 6 months. We examined the 6-month trends of these values. Furthermore, the fasting period post-surgery, the need for swallowing rehabilitation by a speech therapist, and postoperative pneumonia episodes were set as outcomes reflecting the short-term swallowing function. We determined the associations between these outcomes and patient background factors. Results: Postoperatively, the Hyodo score worsened at 1 month but recovered at 3 months. The Hyodo scores of all patients who underwent postcricoid ELPS did not worsen. The diameter of the resected specimen (DRS) was significantly associated with the need for swallowing rehabilitation and postoperative fasting time. A DRS ≥ 35 mm was considered the threshold for the need of swallowing rehabilitation, postoperative pneumonia, and prolonged postoperative fasting time. Conclusion: ELPS exerts a temporal and limited impact on the swallowing function, which recovers within 3 months in every swallowing evaluation. This necessitates additional care during the treatment of patients with mucosal defects ≥ 35 mm, owing to the significant association between the DRS and short-term swallowing function.
AB - Background: Endoscopic laryngopharyngeal surgery (ELPS) is a minimally invasive transoral surgery for superficial pharyngeal and laryngeal cancer, but dysphagia occasionally occurs post-treatment. We investigated dysphagia following ELPS and its risk factors. Methods: Of the 145 patients who underwent ELPS, 92 were evaluated in this study using the Hyodo score, Functional Outcome Swallowing Scale, Eating Assessment Tool-10 along with the total scores for the three items of the method of intake, time, and food preoperatively and on postoperative 1, 3, and 6 months. We examined the 6-month trends of these values. Furthermore, the fasting period post-surgery, the need for swallowing rehabilitation by a speech therapist, and postoperative pneumonia episodes were set as outcomes reflecting the short-term swallowing function. We determined the associations between these outcomes and patient background factors. Results: Postoperatively, the Hyodo score worsened at 1 month but recovered at 3 months. The Hyodo scores of all patients who underwent postcricoid ELPS did not worsen. The diameter of the resected specimen (DRS) was significantly associated with the need for swallowing rehabilitation and postoperative fasting time. A DRS ≥ 35 mm was considered the threshold for the need of swallowing rehabilitation, postoperative pneumonia, and prolonged postoperative fasting time. Conclusion: ELPS exerts a temporal and limited impact on the swallowing function, which recovers within 3 months in every swallowing evaluation. This necessitates additional care during the treatment of patients with mucosal defects ≥ 35 mm, owing to the significant association between the DRS and short-term swallowing function.
UR - http://www.scopus.com/inward/record.url?scp=85147903196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147903196&partnerID=8YFLogxK
U2 - 10.1007/s10147-023-02309-x
DO - 10.1007/s10147-023-02309-x
M3 - Article
C2 - 36780098
AN - SCOPUS:85147903196
SN - 1341-9625
VL - 28
SP - 521
EP - 530
JO - International Journal of Clinical Oncology
JF - International Journal of Clinical Oncology
IS - 4
ER -